Relationship between expression level of 15-PGDH and clinical prognosis of liver transplantation for hepatocellular carcinoma

Li Haibo; Wang Guoying; Zeng Kaining; Zhang Jianwen; Tang Hui; Liu Wei; Yang Yang

doi:10.3969/j.issn.1674-7445.2020.02.010

Volume 11 Issue 2

Mar. 2020

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2020 > 11(2): 247-252, 281

Li Haibo, Wang Guoying, Zeng Kaining, et al. Relationship between expression level of 15-PGDH and clinical prognosis of liver transplantation for hepatocellular carcinoma[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 247-252, 281. doi: 10.3969/j.issn.1674-7445.2020.02.010

Citation:

PDF( 1713 KB)

Relationship between expression level of 15-PGDH and clinical prognosis of liver transplantation for hepatocellular carcinoma

doi: 10.3969/j.issn.1674-7445.2020.02.010

Department of Hepatic Surgery, Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Organ Transplantation Institute of Sun Yat-sen University, Organ Transplantation Research Center of Guangdong Province, Guangdong Key Laboratory of Liver Disease Research, Guangdong Province Engineering Laboratory for Transplantation Medicine, Guangzhou 510630, China

More Information

Corresponding author: Yang Yang, Email: yysysu@163.com
Received Date: 2019-12-27
Available Online: 2021-01-19
Publish Date: 2020-03-15

Abstract

Abstract

Objective To investigate the relationship between the expression level of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and clinical prognosis of liver transplantation for hepatocellular carcinoma. Methods The clinical data of 94 recipients undergoing liver transplantation for hepatocellular carcinoma were retrospectively analyzed. The expression of 15-PGDH in the pathological tissues of all recipients was detected by immunohistochemical staining. The relationship between the expression level of 15-PGDH protein and clinical parameters of hepatocellular carcinoma patients was analyzed. The 5-year tumor-free survival and overall survival rates of liver transplant recipients were calculated. The possible independent risk factors of the clinical prognosis of liver transplant recipients were analyzed. Results The expression level of 15-PGDH was significantly correlated with age, Child-Pugh grade and preoperative level of alpha-fetoprotein (AFP) of the recipients (all P < 0.05). The tumor-free survival and overall survival rates of the recipients with low expression of 15-PGDH were significantly lower than those in their counterparts with high expression of 15-PGDH (both P < 0.05). The expression level of 15-PGDH, degree of tumor differentiation and American Joint Committee on Cancer (AJCC) staging were the independent risk factors of clinical prognosis of liver transplantation for hepatocellular carcinoma (all P < 0.05). Conclusions The expression level of 15-PGDH is an independent risk factor of clinical prognosis of liver transplantation for hepatocellular carcinoma.
- Hepatocellular carcinoma,
- Liver transplantation,
- 15- hydroxyprostaglandin dehydrogenase (15-PGDH),
- Clinical prognosis,
- Risk factor,
- Tumor-free survival

FullText(HTML)

References(30)

References

[1]	KHEMLINA G, IKEDA S, KURZROCK R. The biology of hepatocellular carcinoma: implications for genomic and immune therapies[J]. Mol Cancer, 2017, 16(1):149. DOI: 10.1186/s12943-017-0712-x.
[2]	SANTOPAOLO F, LENCI I, MILANA M, et al. Liver transplantation for hepatocellular carcinoma: where do we stand?[J]. World J Gastroenterol, 2019, 25(21):2591-2602. DOI: 10.3748/wjg.v25.i21.2591.
[3]	SAPISOCHIN G, BRUIX J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(4):203-217. DOI: 10.1038/nrgastro.2016.193.
[4]	GUNSAR F. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria[J]. Exp Clin Transplant, 2017, 15(Suppl 2):59-64. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM18727702
[5]	PAVEL MC, FUSTER J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: future directions[J]. World J Gastroenterol, 2018, 24(32):3626-3636. DOI: 10.3748/wjg.v24.i32.3626.
[6]	LEE JE, ZHONG X, LEE JY, et al. 15-Keto prostaglandin E₂ induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells[J]. Arch Biochem Biophys, 2019:108162. DOI: 10.1016/j.abb.2019.108162.
[7]	PRIMA V, KALIBEROVA LN, KALIBEROV S, et al. COX2/mPGES1/PGE₂ pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells[J]. Proc Natl Acad Sci U S A, 2017, 114(5):1117-1122. DOI: 10.1073/pnas.1612920114.
[8]	KIM HB, KIM M, PARK YS, et al. Prostaglandin E₂ activates YAP and a positive-signaling loop to promote colon regeneration after colitis but also carcinogenesis in mice[J]. Gastroenterology, 2017, 152(3):616-630. DOI: 10.1053/j.gastro.2016.11.005.
[9]	CORWIN C, NIKOLOPOULOU A, PAN AL, et al. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets[J]. J Neuroinflammation, 2018, 15(1):272. DOI: 10.1186/s12974-018-1305-3.
[10]	AL-NAJJAR BO. Investigation of 15-hydroxyprostaglandin dehydrogenase catalytic reaction mechanism by molecular dynamics simulations[J]. J Mol Graph Model, 2018, 80:190-196. DOI: 10.1016/j.jmgm.2018.01.012.
[11]	JANG HO, LEE HN, WOO JH, et al. 15-Deoxy-Δ12, 14-prostaglandin J2 up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation[J]. Free Radic Res, 2019, 53(3):335-347. DOI: 10.1080/10715762.2019.1576867.
[12]	YIN J, XIA W, ZHANG Y, et al. Role of dihydroartemisinin in regulating prostaglandin E₂ synthesis cascade and inflammation in endothelial cells[J]. Heart Vessels, 2018, 33(11):1411-1422. DOI: 10.1007/s00380-018-1190-9.
[13]	ZHANG S, LIU J, YANG M, et al. Single nucleotide polymorphism rs2555639 in 15-PGDH and colorectal cancer metastasis[J]. J BUON, 2019, 24(4):1507-1511.
[14]	PARK JM, NA HK. 15-Deoxy-Δ12, 14-prostaglandin J2 upregulates the expression of 15-hydroxyprostaglandin dehydrogenase by inducing AP-1 activation and heme oxygenase-1 expression in human colon cancer cells[J]. J Cancer Prev, 2019, 24(3):183-191. DOI: 10.15430/JCP. 2019.24.3.183.
[15]	ARIMA K, OHMURAYA M, MIYAKE K, et al. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E₂-ALDH1 signaling in the pancreas[J]. Oncogene, 2019, 38(8):1211-1224. DOI: 10.1038/s41388-018-0510-y.
[16]	PARK YS, LEE JH, JUNG DB, et al. MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma[J]. Sci Rep, 2018, 8(1):17717. DOI: 10.1038/s41598-018-36139-z.
[17]	ARIMA K, KOMOHARA Y, BU L, et al. Downregulation of15-hydroxyprostaglandin dehydrogenase by interleukin-1βfrom activated macrophages leads to poor prognosis in pancreatic cancer[J]. Cancer Sci, 2018, 109(2):462-470. DOI: 10.1111/cas.13467.
[18]	ZHAO J, WEN S, WANG X, et al. Helicobacter pylori modulates cyclooxygenase-2 and 15-hydroxy prostaglandin dehydrogenase in gastric cancer[J]. Oncol Lett, 2017, 14(5):5519-5525. DOI: 10.3892/ol.2017.6843.
[19]	YANG DH, RYU YM, LEE SM, et al. 15-Hydroxyprostaglandin dehydrogenase as a marker in colon carcinogenesis: analysis of the prostaglandin pathway in human colonic tissue[J]. Intest Res, 2017, 15(1):75-82. DOI: 10.5217/ir.2017.15.1.75.
[20]	YANG JE, PARK E, LEE HJ, et al. Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma[J]. Clin Mol Hepatol, 2014, 20(1):28-37. DOI: 10.3350/cmh.2014.20.1.28.
[21]	CASTRO-SÁNCHEZ L, AGRA N, LLORENTE IZQUIERDO C, et al. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma[J]. Int J Biochem Cell Biol, 2013, 45(11):2501-2511. DOI: 10.1016/j.biocel.2013.08.005.
[22]	LORENTE L. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma[J]. World J Gastroenterol, 2018, 24(37):4230-4242. DOI: 10.3748/wjg.v24.i37.4230.
[23]	ZHENG J, CAI J, LI H, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a Meta-analysis and systematic review[J]. Cell Physiol Biochem, 2017, 44(3):967-981. DOI: 10.1159/000485396.
[24]	MORI S, CHOI Y, PARK MS, et al. Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation[J]. Hepatogastroenterology, 2014, 61(136):2353-2358. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=24c277780b0fbe1983c8b45ba2c22a5e
[25]	WANG J, CHO NL, ZAUBER AG, et al. Chemopreventive efficacy of the cyclooxygenase-2 (Cox-2) inhibitor, celecoxib, is predicted by adenoma expression of Cox-2 and 15-PGDH[J]. Cancer Epidemiol Biomarkers Prev, 2018, 27(7):728-736. DOI: 10.1158/1055-9965.EPI-17-0573.
[26]	MEHDAWI LM, SATAPATHY SR, GUSTAFSSON A, et al. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells[J]. Oncotarget, 2017, 8(21):35033-35047. DOI: 10.18632/oncotarget.16591.
[27]	ALGRA AM, ROTHWELL PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials[J]. Lancet Oncol, 2012, 13(5):518-527. DOI: 10.1016/S1470-2045(12)70112-2.
[28]	BURN J, GERDES AM, MACRAE F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial[J]. Lancet, 2011, 378(9809):2081-2087. DOI: 10.1016/S0140-6736(11)61049-0.
[29]	FINK SP, DAWSON DM, ZHANG Y, et al. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs[J]. Carcinogenesis, 2015, 36(2):291-298. DOI: 10.1093/carcin/bgu241.
[30]	TAI HH, CHI X, TONG M. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs)[J]. Prostaglandins Other Lipid Mediat, 2011, 96(1/2/3/4):37-40. DOI: 10.1016/j.prostaglandins.2011.06.005.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (103) PDF downloads(11)

Relationship between expression level of 15-PGDH and clinical prognosis of liver transplantation for hepatocellular carcinoma

doi: 10.3969/j.issn.1674-7445.2020.02.010

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Relationship between expression level of 15-PGDH and clinical prognosis of liver transplantation for hepatocellular carcinoma

doi: 10.3969/j.issn.1674-7445.2020.02.010

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content